Obesity, diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
The interventions used in the original WRAP trial (ISRCTN82857232) included: brief intervention (brief advice and self-help materials
BI), referral to a commercial open-group behavioural programme (Weight Watchers) for 12 weeks (CP12), and referral to the same programme for 52 weeks (CP52). Participant details were entered into the
Sponsors
University of Cambridge
Cambridgeshire and Peterborough NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants who took part in the original WRAP study and consented for further follow up
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5 year (and 10 year) changes in weight, adjusted for baseline. Participants will be weighed at their local GP surgery using calibrated scales. Where participants are unable/unwilling to attend a visit the trialists will obtain a weight measurement from NHS records and/or self-report. | — |
Secondary
| Measure | Time frame |
|---|---|
| 5 year changes (and 10 year changes) in: 1. Fat mass, measured by Tanita body composition analyser 2. HbA1C and lipid profile, measured by blood sample and analysed used standardised methods 3. Blood pressure, measured using OMRON meter in a resting state 4. Diabetes status (normoglycaemia, non-diabetic hyperglycaemia and diabetes) 5. Modelled 10-year cardiovascular risk (Q-Risk) | — |
Countries
England, United Kingdom
Contacts
Public ContactJenny Woolston
Outcome results
None listed